ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,321.41
      0.25%
      US Tech 100
      18,240.80
      0.24%
      Dow Jones
      39,872.99
      0.17%
      Brent Oil
      82.445
      -1.30%
      Bitcoin
      70,153.18
      -1.80%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lyra Therapeutics Inc (LYRA)

      7. Lyra Therapeutics Inc (LYRA) News

      LYRA

      Lyra Therapeutics (LYRA)

      Lyra Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LYRA
      DateTimeSourceHeadlineSymbolCompany
      05/21/20249:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
      05/21/20249:14AMGlobeNewswire Inc.Lyra Therapeutics Announces Cost-Cutting Measures to Preserve CapitalNASDAQ:LYRALyra Therapeutics Inc
      05/06/20247:59AMGlobeNewswire Inc.Lyra Therapeutics Reports Topline Results from Phase 3 ENLIGHTEN 1 Trial for LYR-210 in Chronic RhinosinusitisNASDAQ:LYRALyra Therapeutics Inc
      04/30/20244:04PMGlobeNewswire Inc.Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:LYRALyra Therapeutics Inc
      04/26/20244:51PMGlobeNewswire Inc.Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LYRALyra Therapeutics Inc
      03/21/20244:01PMGlobeNewswire Inc.Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:LYRALyra Therapeutics Inc
      03/01/20244:01PMGlobeNewswire Inc.Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LYRALyra Therapeutics Inc
      02/15/20249:18AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LYRALyra Therapeutics Inc
      02/14/20248:35PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LYRALyra Therapeutics Inc
      02/14/20246:18PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LYRALyra Therapeutics Inc
      02/14/20244:51PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LYRALyra Therapeutics Inc
      02/14/20244:18PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LYRALyra Therapeutics Inc
      02/13/20244:34PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LYRALyra Therapeutics Inc
      02/01/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
      02/01/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
      01/08/20246:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
      12/28/20236:40AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
      12/18/20234:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
      11/16/20235:00PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LYRALyra Therapeutics Inc
      11/13/20235:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYRALyra Therapeutics Inc
      11/07/20234:23PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LYRALyra Therapeutics Inc
      11/07/20234:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
      11/07/20234:01PMGlobeNewswire Inc.Lyra Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:LYRALyra Therapeutics Inc
      11/07/20237:00AMGlobeNewswire Inc.Lyra Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:LYRALyra Therapeutics Inc
      10/16/20237:00AMGlobeNewswire Inc.Lyra Therapeutics Announces Appointment of Ronan O’Brien as Chief Legal OfficerNASDAQ:LYRALyra Therapeutics Inc
      09/12/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
      09/12/20237:00AMGlobeNewswire Inc.Lyra Therapeutics Announces Positive Topline Results from BEACON Phase 2 Study of LYR-220 for the Treatment of Chronic Rhinosinusitis (CRS) in Patients with Prior Ethmoid Sinus SurgeryNASDAQ:LYRALyra Therapeutics Inc
      09/06/20238:00AMGlobeNewswire Inc.Lyra Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:LYRALyra Therapeutics Inc
      09/01/20234:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYRALyra Therapeutics Inc
      09/01/20234:01PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LYRALyra Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:LYRA

      Your Recent History

      USOTC
      AEORF
      AEON REIT Investment (PK)
      COIN
      KGSLEUR
      KYRGYZ SOM
      Delayed Upgrade Clock